{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:10:45Z","timestamp":1791083445688,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi and Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.dmpk.2024.101032","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T04:02:03Z","timestamp":1725940923000},"page":"101032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Understanding mechanisms of negative food effect for voclosporin using physiologically based pharmacokinetic modeling"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9759-6071","authenticated-orcid":false,"given":"Ayahisa","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Akazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-7041","authenticated-orcid":false,"given":"Motohiro","family":"Fujiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2024.101032_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1039\/C4SC03089C","article-title":"Macrocycles: lessons from the distant past, recent developments, and future directions","volume":"6","author":"Yudin","year":"2015","journal-title":"Chem Sci"},{"issue":"7","key":"10.1016\/j.dmpk.2024.101032_bib2","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/jm1012374","article-title":"Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery","volume":"54","author":"Marsault","year":"2011","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.dmpk.2024.101032_bib3","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1021\/acsmedchemlett.2c00310","article-title":"Highly potent and oral macrocyclic peptides as a HIV-1 protease inhibitor: mRNA display-derived hit-to-lead optimization","volume":"13","author":"Kusumoto","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.dmpk.2024.101032_bib4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.5059\/yukigoseikyokaishi.75.1171","article-title":"Constrained peptides in drug discovery and development","volume":"75","author":"Cary","year":"2017","journal-title":"J Synth Org Chem, Jpn"},{"issue":"12","key":"10.1016\/j.dmpk.2024.101032_bib5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/17460441.2016.1245720","article-title":"Discovery and optimization of peptide macrocycles","volume":"11","author":"White","year":"2016","journal-title":"Expet Opin Drug Discov"},{"key":"10.1016\/j.dmpk.2024.101032_bib6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrd2590","article-title":"The exploration of macrocycles for drug discovery -- an underexploited structural class","volume":"7","author":"Driggers","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.dmpk.2024.101032_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.addr.2016.03.013","article-title":"Cell permeability beyond the rule of 5","volume":"101","author":"Matsson","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.dmpk.2024.101032_bib8","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.xphs.2022.03.019","article-title":"Optimization of cyclic peptide property using chromatographic capacity factor on permeability of passive cell membrane and human induced pluripotent stem cell-derived intestinal membrane","volume":"111","author":"Watanabe","year":"2022","journal-title":"J Pharmaceut Sci"},{"issue":"24","key":"10.1016\/j.dmpk.2024.101032_bib9","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1021\/acs.jmedchem.8b01259","article-title":"Lipophilic permeability efficiency reconciles the opposing roles of lipophilicity in membrane permeability and aqueous solubility","volume":"61","author":"Naylor","year":"2018","journal-title":"J Med Chem"},{"issue":"10289","key":"10.1016\/j.dmpk.2024.101032_bib11","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.dmpk.2024.101032_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jcph.114","article-title":"Voclosporin food effect and single oral ascending dose pharmacokinetic and pharmacodynamic studies in healthy human subjects","volume":"53","author":"Mayo","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2024.101032_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2215\/CJN.01531005","article-title":"Large within\u2010day variation in cyclosporine absorption: circadian variation or food effect?","volume":"17","author":"Curtis","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.dmpk.2024.101032_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/00912700122009999","article-title":"Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects","volume":"41","author":"Bekersky","year":"2001","journal-title":"J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.dmpk.2024.101032_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/pharmaceutics12070672","article-title":"Food effects on oral drug absorption: application of physiologically-based pharmacokinetic modeling as a predictive tool","volume":"12","author":"Cheng","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.dmpk.2024.101032_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2023.100502","article-title":"Evaluation and prediction of oral drug absorption and bioequivalence with food-druginteraction","volume":"50","author":"Tsume","year":"2023","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2024.101032_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejps.2014.04.008","article-title":"Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: In vitro experimental simulation and computational verification","volume":"61","author":"Cviji\u0107","year":"2014","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.dmpk.2024.101032_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejps.2017.03.011","article-title":"Mechanistic investigation of the negative food effect of modified release zolpidem","volume":"102","author":"Andreas","year":"2017","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.dmpk.2024.101032_bib20","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/jphp.13161","article-title":"Dressman JB In-vitro\u2013in-silico investigation of the negative food effect of zolpidem when administered as immediate-release tablets","volume":"71","author":"Paraiso","year":"2019","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"10.1016\/j.dmpk.2024.101032_bib21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/bcp.12309","article-title":"Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin","volume":"77","author":"Ling","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmpk.2024.101032_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.1013","article-title":"Physiologically based pharmacokinetic model qualification and reporting procedures for regulatory submissions: a consortium perspective","volume":"104","author":"Shebley","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.dmpk.2024.101032_bib23","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1124\/dmd.118.083246","article-title":"Application of intestinal epithelial cells differentiated from human induced pluripotent stem cells for studies of prodrug hydrolysis and drug absorption in the small intestine","volume":"46","author":"Akazawa","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmpk.2024.101032_bib24","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.xphs.2019.12.019","article-title":"Successful prediction of human pharmacokinetics after oral administration by optimized physiologically based pharmacokinetics approach and permeation assay using human induced pluripotent stem cell-derived intestinal epithelial cells","volume":"109","author":"Mayumi","year":"2020","journal-title":"J Pharmaceut Sci"},{"issue":"13","key":"10.1016\/j.dmpk.2024.101032_bib25","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1084\/jem.20100844","article-title":"Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells","volume":"207","author":"Takayama","year":"2010","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.dmpk.2024.101032_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.stemcr.2017.11.004","article-title":"A refined culture system for human induced pluripotent stem cell-derived intestinal epithelial organoids","volume":"10","author":"Takahashi","year":"2018","journal-title":"Stem Cell Rep"},{"issue":"9","key":"10.1016\/j.dmpk.2024.101032_bib27","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/jps.24258","article-title":"Direct in vivo human intestinal permeability (Peff) determined with different clinical perfusion and intubation methods","volume":"104","author":"Dahlgren","year":"2015","journal-title":"J Pharmaceut Sci"},{"issue":"8","key":"10.1016\/j.dmpk.2024.101032_bib28","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11095-006-9041-2","article-title":"Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model","volume":"23","author":"Cao","year":"2006","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.dmpk.2024.101032_bib29","series-title":"Biopharmaceutics modeling and simulations: theory, practice, methods, and applications","author":"Sugano","year":"2012"},{"issue":"1","key":"10.1016\/j.dmpk.2024.101032_bib30","first-page":"106","article-title":"Prediction of oral absorption of low-solubility drugs by using rat simulated gastrointestinal fluids: the importance of regional differences in membrane permeability and solubility","volume":"17","author":"Tanaka","year":"2014","journal-title":"J Pharm Pharmaceut Sci"},{"issue":"1","key":"10.1016\/j.dmpk.2024.101032_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","article-title":"Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments","volume":"60","author":"McConnell","year":"2008","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.dmpk.2024.101032_bib32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2174\/138920010794328913","article-title":"Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the \u201cAdvanced Dissolution, Absorption, Metabolism (ADAM)\u201d model","volume":"11","author":"Darwich","year":"2010","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.dmpk.2024.101032_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","article-title":"Population-based mechanistic prediction of oral drug absorption","volume":"11","author":"Jamei","year":"2009","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.dmpk.2024.101032_bib34","first-page":"46","article-title":"The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data","volume":"283","author":"Obach","year":"1997","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"12","key":"10.1016\/j.dmpk.2024.101032_bib35","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1002\/jps.21759","article-title":"Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods","volume":"98","author":"Poulin","year":"2009","journal-title":"J Pharmaceut Sci"},{"issue":"10","key":"10.1016\/j.dmpk.2024.101032_bib36","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharm Res (N Y)"},{"issue":"9","key":"10.1016\/j.dmpk.2024.101032_bib37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/psp4.12458","article-title":"Physiologically-based pharmacokinetic modeling approach to predict rifampin-mediated intestinal P-glycoprotein induction","volume":"8","author":"Yamazaki","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"7","key":"10.1016\/j.dmpk.2024.101032_bib38","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/psp4.12791","article-title":"Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator","volume":"11","author":"Ezuruike","year":"2022","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"8","key":"10.1016\/j.dmpk.2024.101032_bib40","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/pharmaceutics13081169","article-title":"Mechanistic PBPK modelling to predict the advantage of the salt form of a drug when dosed with acid reducing agents","volume":"13","author":"Chirumamilla","year":"2021","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.dmpk.2024.101032_bib41","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1021\/acs.molpharmaceut.7b00406","article-title":"Model-based analysis of biopharmaceutic experiments to improve mechanistic oral absorption modeling: an integrated in vitro in vivo extrapolation perspective using ketoconazole as a model drug","volume":"14","author":"Pathak","year":"2017","journal-title":"Mol Pharm"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436724000387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436724000387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T20:41:20Z","timestamp":1734036080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436724000387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":38,"alternative-id":["S1347436724000387"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2024.101032","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding mechanisms of negative food effect for voclosporin using physiologically based pharmacokinetic modeling","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2024.101032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101032"}}